Endogenous antibody response to SARS-CoV-2 in patients who received monoclonal antibodies against COVID-19: A systematic review
Passive immunization with mAbs has been employed in COVID-19. We performed a systematic review of the literature assessing the endogenous humoral immune response against SARS-CoV-2 in patients treated with mAbs. Administration of mAbs in seronegative patients led to a reduction in both antibody titr...
Main Authors: | Andrea Lombardi, Cecilia Azzarà, Giulia Renisi, Giulia Viero, Andrea Gori, Alessandra Bandera |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-12-01
|
Series: | Clinical Immunology Communications |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S277261342200018X |
Similar Items
-
Novel Neutralizing Epitope of PEDV S1 Protein Identified by IgM Monoclonal Antibody
by: Techit Thavorasak, et al.
Published: (2022-01-01) -
Preliminary Evidence of Good Safety Profile and Outcomes of Early Treatment with Tixagevimab/Cilgavimab Compared to Previously Employed Monoclonal Antibodies for COVID-19 in Immunocompromised Patients
by: Andrea Lombardi, et al.
Published: (2023-05-01) -
Monoclonal antibodies /
by: Peter, J. H., et al.
Published: (1992) -
Development of Therapeutic Monoclonal Antibodies for Emerging Arbovirus Infections
by: Leonardo F. Ormundo, et al.
Published: (2023-10-01) -
Monoclonal antibodies : the second generation /
by: 186276 Zola, Heddy
Published: (1995)